Document 0062 DOCN M9490062 TI Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety. DT 9411 AU Tsuzuki N; Hama T; Kawada M; Hasui A; Konishi R; Shiwa S; Ochi Y; Futaki S; Kitagawa K; Telkoku Seiyaku Company Ltd., Kagawa, Japan. SO J Pharm Sci. 1994 Apr;83(4):481-4. Unique Identifier : AIDSLINE MED/94322211 AB Five AZT (azidothymidine) prodrugs conjugated with the 1-adamantane moiety via an ester bond were synthesized to improve the transport of AZT into the central nervous system (CNS). In in vitro degradation studies with rat and human plasma, it was demonstrated that the prodrugs were degraded enzymatically and converted quantitatively to their parent drug. AZT. As assessed by octanol-buffer partitioning, the prodrugs were much more lipophilic than AZT and were expected to penetrate the blood-brain barrier (BBB) readily. In in vivo studies, in which the prodrugs were administered intravenously to rat, the prodrugs in brain tissue were detected at 7-18 times higher concentrations than AZT in spite of the negligible amount of the prodrug in the cerebrospinal fluid. These results indicate that the introduction to AZT of the 1-adamantane moiety results in the enhancement of the BBB penetration. This pharmaceutical approach would be beneficial for the efficient treatment of the CNS infection by human immunodeficiency virus. DE Adamantane/*PHARMACOLOGY/PHARMACOKINETICS Animal Blood-Brain Barrier/PHYSIOLOGY Brain/*METABOLISM Chemistry, Physical Chromatography, High Pressure Liquid Drug Carriers Human Hydrolysis In Vitro Male Prodrugs/CHEMICAL SYNTHESIS/*PHARMACOLOGY/PHARMACOKINETICS Rats Rats, Wistar Zidovudine/ANALOGS & DERIVATIVES/ADMINISTRATION & DOSAGE/ *PHARMACOKINETICS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).